User:Rupertdonovan/sandbox: Difference between revisions
Content deleted Content added
Infobox person |
Infobox person |
||
| Line 16: | Line 16: | ||
| website = {{URL|https://fabricgenomics.com}} |
| website = {{URL|https://fabricgenomics.com}} |
||
}} |
}} |
||
'''John R. Stuelpnagel''' is an [[USA|American]] [[venture capitalist]], [[inventor]], [[ medical researcher]] and [[publicist]], specializing in [[biotechnology]].<ref name="MedCityNews">{{cite web|url=https://medcitynews.com/2015/01/future-next-gen-sequencing-illumina-cofounders-never-genome-mapped/|title=The future of next-gen sequencing (and why an Illumina cofounder’s never had his genome mapped) |publisher=MedCityNews}}</ref><ref>{{cite web|url=https://medium.com/@axialxyz/eight-lessons-from-john-stuelpnagel-illumina-ca95ad7b59eb |title=Eight Lessons from John Stuelpnagel (Illumina) |publisher=Medium}}</ref><ref>{{cite web|url=https://min.news/en/tech/764027bcc054ec7384e9c56ab7ef906e.html|title=Illumina's original people are coming soon, and the mysterious Chu CHUANG, who is at the helm of the Chinese executives, has attracted $400 million in 4 years to build a cheaper DNA sequencer |publisher=MinNews }}</ref> He is mostly known for business and research contributions to [[DNA sequencing]] technology through co-founding [[Illumina, Inc.]],<ref name="Illumina">{{Cite web|title=Illumina- The Origin story|url=https://www.linkedin.com/pulse/illumina-origin-story-tony-czarnik|website=www.linkedin.com|language=en}}</ref> |
'''John R. Stuelpnagel''' is an [[USA|American]] [[venture capitalist]], [[inventor]], [[ medical researcher]] and [[publicist]], specializing in [[biotechnology]].<ref name="MedCityNews">{{cite web|url=https://medcitynews.com/2015/01/future-next-gen-sequencing-illumina-cofounders-never-genome-mapped/|title=The future of next-gen sequencing (and why an Illumina cofounder’s never had his genome mapped) |publisher=MedCityNews}}</ref><ref>{{cite web|url=https://medium.com/@axialxyz/eight-lessons-from-john-stuelpnagel-illumina-ca95ad7b59eb |title=Eight Lessons from John Stuelpnagel (Illumina) |publisher=Medium}}</ref><ref>{{cite web|url=https://min.news/en/tech/764027bcc054ec7384e9c56ab7ef906e.html|title=Illumina's original people are coming soon, and the mysterious Chu CHUANG, who is at the helm of the Chinese executives, has attracted $400 million in 4 years to build a cheaper DNA sequencer |publisher=MinNews }}</ref> He is mostly known for business and research contributions to [[DNA sequencing]] technology through co-founding [[Illumina, Inc.]],<ref name="Illumina">{{Cite web|title=Illumina- The Origin story|url=https://www.linkedin.com/pulse/illumina-origin-story-tony-czarnik|website=www.linkedin.com|language=en}}</ref><ref>{{cite web|url=https://seekingalpha.com/article/4381959-illumina-cheap-upside-from-grail |title=Illumina: Cheap With Further Upside From Grail |publisher=Seeking Alpha }}</ref> |
||
Revision as of 00:40, 21 August 2021
John Stuelpnagel | |
|---|---|
| Born | John R. Stuelpnagel |
| Nationality | American |
| Alma mater | University of California, Davis (B.S) (D.V.M.) UCLA Anderson School of Management (MBA) |
| Occupation(s) | Founder and CEO of Illumina, Inc. (1998 - 2009) Chairman and Co-founder of Fabric Genomics (2009 - Present) Chairman of 10x Genomics (2013 - Present) |
| Website | fabricgenomics |
John R. Stuelpnagel is an American venture capitalist, inventor, medical researcher and publicist, specializing in biotechnology.[1][2][3] He is mostly known for business and research contributions to DNA sequencing technology through co-founding Illumina, Inc.,[4][5]
- ^ "The future of next-gen sequencing (and why an Illumina cofounder's never had his genome mapped)". MedCityNews.
- ^ "Eight Lessons from John Stuelpnagel (Illumina)". Medium.
- ^ "Illumina's original people are coming soon, and the mysterious Chu CHUANG, who is at the helm of the Chinese executives, has attracted $400 million in 4 years to build a cheaper DNA sequencer". MinNews.
- ^ "Illumina- The Origin story". www.linkedin.com.
- ^ "Illumina: Cheap With Further Upside From Grail". Seeking Alpha.